Heartseedの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/18 | 2,678 | 2,730 | 2,322 | 2,666 | -112 | -4% | 2,738,600 |
2024/12/17 | 2,491 | 2,830 | 2,433 | 2,778 | +437 | +18.7% | 4,726,300 |
2024/12/16 | 2,121 | 2,341 | 2,120 | 2,341 | +400 | +20.6% | 1,953,500 |
2024/12/13 | 1,628 | 1,960 | 1,601 | 1,941 | +381 | +24.4% | 3,073,300 |
2024/12/12 | 1,580 | 1,605 | 1,542 | 1,560 | -6 | -0.4% | 390,300 |
2024/12/11 | 1,549 | 1,580 | 1,527 | 1,566 | +18 | +1.2% | 196,600 |
2024/12/10 | 1,529 | 1,585 | 1,529 | 1,548 | +1 | +0.1% | 227,300 |
2024/12/09 | 1,547 | 1,568 | 1,511 | 1,547 | +26 | +1.7% | 233,900 |
2024/12/06 | 1,481 | 1,522 | 1,459 | 1,521 | +33 | +2.2% | 164,400 |
2024/12/05 | 1,485 | 1,507 | 1,471 | 1,488 | -15 | -1% | 199,300 |
2024/12/04 | 1,500 | 1,512 | 1,475 | 1,503 | -9 | -0.6% | 173,500 |
2024/12/03 | 1,515 | 1,554 | 1,511 | 1,512 | +7 | +0.5% | 214,400 |
2024/12/02 | 1,560 | 1,560 | 1,500 | 1,505 | -29 | -1.9% | 185,500 |
2024/11/29 | 1,523 | 1,536 | 1,485 | 1,534 | +12 | +0.8% | 256,500 |
2024/11/28 | 1,450 | 1,524 | 1,448 | 1,522 | +73 | +5% | 390,300 |
2024/11/27 | 1,421 | 1,484 | 1,408 | 1,449 | +19 | +1.3% | 237,100 |
2024/11/26 | 1,454 | 1,480 | 1,418 | 1,430 | -24 | -1.7% | 303,900 |
2024/11/25 | 1,473 | 1,478 | 1,418 | 1,454 | +4 | +0.3% | 343,300 |
2024/11/22 | 1,376 | 1,480 | 1,330 | 1,450 | +101 | +7.5% | 483,000 |
2024/11/21 | 1,345 | 1,385 | 1,334 | 1,349 | +6 | +0.4% | 195,000 |
2024/11/20 | 1,318 | 1,407 | 1,304 | 1,343 | +25 | +1.9% | 379,600 |
2024/11/19 | 1,277 | 1,342 | 1,271 | 1,318 | +17 | +1.3% | 192,800 |
2024/11/18 | 1,277 | 1,311 | 1,239 | 1,301 | +5 | +0.4% | 183,100 |
2024/11/15 | 1,300 | 1,317 | 1,250 | 1,296 | -11 | -0.8% | 235,200 |
2024/11/14 | 1,295 | 1,323 | 1,279 | 1,307 | +6 | +0.5% | 159,300 |
2024/11/13 | 1,340 | 1,340 | 1,290 | 1,301 | -36 | -2.7% | 103,700 |
2024/11/12 | 1,340 | 1,377 | 1,325 | 1,337 | -30 | -2.2% | 147,500 |
2024/11/11 | 1,278 | 1,374 | 1,260 | 1,367 | +109 | +8.7% | 277,800 |
2024/11/08 | 1,228 | 1,259 | 1,207 | 1,258 | +33 | +2.7% | 277,600 |
2024/11/07 | 1,263 | 1,320 | 1,224 | 1,225 | -50 | -3.9% | 374,400 |
2024/11/06 | 1,264 | 1,311 | 1,260 | 1,275 | -7 | -0.5% | 246,200 |
2024/11/05 | 1,322 | 1,324 | 1,282 | 1,282 | -33 | -2.5% | 214,900 |
2024/11/01 | 1,352 | 1,367 | 1,312 | 1,315 | -63 | -4.6% | 301,200 |
2024/10/31 | 1,358 | 1,408 | 1,357 | 1,378 | +23 | +1.7% | 199,000 |
2024/10/30 | 1,368 | 1,410 | 1,331 | 1,355 | +28 | +2.1% | 406,200 |
2024/10/29 | 1,301 | 1,348 | 1,282 | 1,327 | +41 | +3.2% | 273,900 |
2024/10/28 | 1,229 | 1,308 | 1,216 | 1,286 | +36 | +2.9% | 371,200 |
2024/10/25 | 1,333 | 1,354 | 1,241 | 1,250 | -106 | -7.8% | 563,200 |
2024/10/24 | 1,318 | 1,377 | 1,315 | 1,356 | +13 | +1% | 323,600 |
2024/10/23 | 1,330 | 1,350 | 1,290 | 1,343 | -21 | -1.5% | 327,300 |
2024/10/22 | 1,348 | 1,374 | 1,319 | 1,364 | +6 | +0.4% | 423,400 |
2024/10/21 | 1,463 | 1,473 | 1,351 | 1,358 | -122 | -8.2% | 1,031,300 |
2024/10/18 | 1,501 | 1,573 | 1,469 | 1,480 | -35 | -2.3% | 867,800 |
2024/10/17 | 1,597 | 1,597 | 1,485 | 1,515 | +51 | +3.5% | 1,802,700 |
2024/10/16 | 1,522 | 1,522 | 1,456 | 1,464 | -75 | -4.9% | 468,000 |
2024/10/15 | 1,498 | 1,609 | 1,442 | 1,539 | +101 | +7% | 1,319,300 |
2024/10/11 | 1,476 | 1,477 | 1,417 | 1,438 | -38 | -2.6% | 463,100 |
2024/10/10 | 1,510 | 1,524 | 1,475 | 1,476 | -39 | -2.6% | 443,800 |
2024/10/09 | 1,607 | 1,607 | 1,500 | 1,515 | -69 | -4.4% | 769,500 |
2024/10/08 | 1,576 | 1,611 | 1,522 | 1,584 | -31 | -1.9% | 1,120,800 |
151~
200
件表示中 / 247件
類似銘柄と比較する
現在ご覧いただいている「ハートシード」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 223,600円 | +4.1% | -3.1% | 2.59% | 19.42倍 | 1.69倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 92,300円 | +20.3% | - | 0.00% | 163.65倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 246,300円 | +16.9% | +33.2% | 2.23% | 13.43倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム